Cormorant Asset Management as of June 30, 2018
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 57 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nektar Therapeutics (NKTR) | 12.0 | $163M | 3.3M | 48.83 | |
| Apellis Pharmaceuticals (APLS) | 7.0 | $95M | 4.3M | 22.00 | |
| Mirati Therapeutics | 7.0 | $95M | 1.9M | 49.30 | |
| Anaptysbio Inc Common (ANAB) | 6.5 | $88M | 1.2M | 71.04 | |
| Inflarx Nv (IFRX) | 3.5 | $48M | 1.5M | 32.25 | |
| Dicerna Pharmaceuticals | 3.3 | $44M | 3.6M | 12.25 | |
| Avrobio Ord (AVRO) | 3.2 | $43M | 1.5M | 28.56 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 3.0 | $41M | 1.5M | 26.79 | |
| Myokardia | 2.8 | $38M | 767k | 49.53 | |
| Sage Therapeutics (SAGE) | 2.8 | $38M | 240k | 156.53 | |
| Blueprint Medicines (BPMC) | 2.6 | $35M | 550k | 63.48 | |
| Quotient | 2.5 | $35M | 4.3M | 8.03 | |
| G1 Therapeutics | 2.3 | $31M | 720k | 43.46 | |
| Rocket Pharmaceuticals (RCKT) | 2.2 | $30M | 1.5M | 19.63 | |
| Theravance Biopharma (TBPH) | 2.2 | $30M | 1.3M | 22.68 | |
| Tricida | 2.1 | $28M | 935k | 29.90 | |
| Kezar Life Sciences (KZR) | 2.0 | $27M | 1.6M | 17.30 | |
| Spectrum Pharmaceuticals | 1.9 | $25M | 1.2M | 20.96 | |
| Ascendis Pharma A S (ASND) | 1.8 | $25M | 372k | 66.52 | |
| Tesaro | 1.8 | $25M | 550k | 44.47 | |
| Solid Biosciences | 1.8 | $24M | 686k | 35.63 | |
| Omeros Corporation (OMER) | 1.8 | $24M | 1.3M | 18.14 | |
| Argenx Se (ARGX) | 1.7 | $23M | 279k | 82.86 | |
| Arena Pharmaceuticals | 1.4 | $20M | 450k | 43.60 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $19M | 191k | 98.24 | |
| Vanda Pharmaceuticals (VNDA) | 1.4 | $18M | 958k | 19.05 | |
| Omeros | 1.3 | $18M | 969k | 18.14 | |
| Reata Pharmaceuticals Inc Cl A | 1.2 | $16M | 450k | 34.97 | |
| Kiniksa Pharmaceuticals | 1.0 | $14M | 831k | 16.66 | |
| Incyte Corporation (INCY) | 1.0 | $13M | 200k | 67.00 | |
| Clearside Biomedical (CLSD) | 0.9 | $13M | 1.2M | 10.69 | |
| Audentes Therapeutics | 0.9 | $12M | 323k | 38.21 | |
| Quanterix Ord (QTRX) | 0.9 | $12M | 848k | 14.36 | |
| Inspire Med Sys (INSP) | 0.9 | $12M | 325k | 35.66 | |
| Array BioPharma | 0.8 | $11M | 669k | 16.78 | |
| Biohaven Pharmaceutical Holding | 0.8 | $11M | 285k | 39.52 | |
| Gemphire Therapeutics | 0.8 | $11M | 1.0M | 10.19 | |
| Aclaris Therapeutics (ACRS) | 0.8 | $11M | 526k | 19.97 | |
| Abeona Therapeutics | 0.7 | $8.8M | 549k | 16.00 | |
| Zai Lab (ZLAB) | 0.6 | $7.7M | 333k | 23.25 | |
| Heron Therapeutics (HRTX) | 0.6 | $7.4M | 191k | 38.85 | |
| Contrafect | 0.6 | $7.5M | 3.4M | 2.21 | |
| Eidos Therapeutics | 0.6 | $7.5M | 386k | 19.32 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.5 | $6.8M | 287k | 23.85 | |
| Translate Bio | 0.4 | $5.8M | 455k | 12.65 | |
| Sangamo Biosciences (SGMO) | 0.4 | $5.4M | 382k | 14.20 | |
| Iterum Therapeutics | 0.4 | $5.4M | 500k | 10.89 | |
| Minerva Neurosciences | 0.4 | $5.0M | 608k | 8.25 | |
| Acceleron Pharma | 0.3 | $3.5M | 72k | 48.52 | |
| Marinus Pharmaceuticals | 0.2 | $3.4M | 478k | 7.07 | |
| Trillium Therapeutics, Inc. Cmn | 0.2 | $3.4M | 573k | 6.00 | |
| Intec Pharma | 0.2 | $3.4M | 774k | 4.40 | |
| Scholar Rock Hldg Corp (SRRK) | 0.2 | $3.3M | 210k | 15.60 | |
| Meiragtx Holdings (MGTX) | 0.2 | $2.7M | 239k | 11.46 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $2.6M | 382k | 6.72 | |
| Cellectar Biosciences Equity Warrants *w | 0.0 | $10k | 53k | 0.19 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $21k | 417k | 0.05 |
